Abstract
Clostridium difficile(CD), a gram-positive, spore-forming, obligate anaerobic bacillus, is a leading cause of antibiotic-associated diarrhea(AAD)worldwide.With the widespread use of broad-spectrum antibiotics, the incidence of clostridium difficile infection in children is rising, while recurrent clostridium difficile infection(RCDI)requires prolonged treatment and higher medical costs.Malignancy, recent surgery and antibiotic exposures have been identified as the risk factors in children.While the toxigenic strains culture and the cell cytotoxicity neutralization assay are gold standard for the diagnosis, new diagnostic approaches such as nucleic acid amplification method have become available.The use of antibiotics, fecal microbiota transplantation(FMT)or monoclonal antibodies are included in the current treatments for RCDI.This review will cover published studies to discuss the risk factors, diagnosis and treatment of RCDI in children. Key words: Recurrent clostridium difficile infection; Antibiotic-associated diarrhea; Children
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
